Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

OrthAlign Reaches Milestone in Orthopedic Surgery at Hospital for Special Surger

OrthAlign, Inc., a pioneering medical device company that provides orthopedic surgeons with advanced precision computer-assisted technology, is celebrating the 16,500th procedure at Hospital for Special Surgery (HSS) with 25 of its surgeons using its technology in hip and knee replacements.

OrthAlign is a handheld navigation device that allows for accurate component positioning for total and partial knee and total hip arthroplasty. The next generation platform weighs only 7 ounces and is designed to improve results through simple workflows.

OrthAlign, Inc., is celebrating the 16,500th procedure at Hospital for Special Surgery (HSS).

It is more efficient and cost effective than previous surgical technologies, as it can be used without the financial investment, pre-operative imaging, or processes required by many robotic or computer-assisted surgical systems.

“This is another great milestone for our organization, says Eric Timko, Chairman and CEO of OrthAlign, Inc. “Technology in every room and in every case is the future; OrthAlign is the catalyst to make that happen.”

OrthAlign consists of one single-use disposable unit and one tray per patient case. This meets the needs of multiple operating rooms, increasing the number of surgeries that can be performed per facility. In addition, it shortens operating room time and reduces the cost to surgeons and patients. It is run on an Android system and is compatible with standard implant systems.

“Using OrthAlign technology allows me to accurately execute my cuts in TKA. The system is simple, and it allows me to have the freedom to adjust my game plan intraoperatively,” says orthopedic surgeon Dr. Cynthia Kahlenberg.

“Without a lot of extra work or planning, I can get all the important information out of the system – perfect alignment and reliability.” says Dr. Mike Ast, an orthopedic surgeon.

Dr. Michael Parks, orthopedic surgeon, says, “using OrthAlign provides me added confidence in the accuracy of the cuts I perform in TKA. This is especially useful in patients with difficult anatomy and in obese patients to ensure satisfactory placement of the knee components.”

Dr. Brian Chalmers, also an orthopedic surgeon, adds “OrthAlign navigation gives me the control and confidence to set individualized alignment targets for different patients to optimize their soft tissue balance and outcomes.”

The handheld navigation technology is currently being used in hospitals and surgical facilities across the country.

In November of 2021 the company launched Lantern®, its newest technology, which builds upon the clinical success of OrthAlign; it has since become the company’s flagship product. It provides orthopedic surgeons with a state-of-the-art device for improving outcomes of total and partial knee replacement surgery.

Timko says he is excited to reach this milestone with HSS, which is consistently ranked Number 1 in orthopedics nationwide by U.S. News & World Report and worldwide by Newsweek, and has facilities in New York, New Jersey, Connecticut, and Florida.

He looks forward to more milestones in the future. “We are committed to making empowering technologies accessible to all. We believe the future is bright.”

OrthAlign, Inc., is a privately held U.S.-based medical device company that provides orthopedic surgeons with advanced precision computer-assisted technologies designed to deliver healthier and more pain-free lifestyles to joint replacement patients.

Driven by the belief that everyone deserves exceptional healthcare, we are committed to making empowering technologies accessible to all.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy